The Foxp3+ SIs in breast cancer PTs were significantly higher than those of benign breast diseases and normal breast tissues, which were 3.50 ± 1.04%, 0.71 ± 0.42%, and 0.55 ± 0.34%, respectively, (P < 0.05). Here, FOXP3 is linked to breast cancer.